Economic Burden of HIV in a Commercially Insured Population in the United States

**Background:** With advances in antiretroviral therapy (ART), people with HIV infection are living longer. Pre-exposure prophylaxis (PrEP) to reduce HIV infection risk continues to be underutilized in high-risk individuals. Recent data on economic burden for patients with newly diagnosed HIV-1 or i...

Full description

Bibliographic Details
Main Authors: Cindy Y. Chen, Prina Donga, Alicia K. Campbell, Babafemi Taiwo
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2023-01-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.56928